-transparent.png){kind=logo}
RU 486 [17 beta-hydroxy-11 beta-(4-dimethylaminophenyl)17 alpha-(prop-1-ynyl)estra-4,9-dien-3-one] is a steroid analog which antagonizes glucocorticoid action at the receptor level. The pituitary-adrenal response to RU 486 was evaluated in patients with Cushing's syndrome. The acute administration of 400 mg RU 486 at 0800 h in five patients with Cushing's disease induced no significant change in plasma cortisol during the next 10 h compared with the administration of placebo. However, prolonged administration (400 mg daily for 3 days) caused activation of the pituitary-adrenal axis; urinary cortisol increased the most from 727 to 5720, 830 to 8200, 610 to 1020, 110 to 570, and 300 to 990 micrograms/day. Plasma cortisol and lipotropins increased to a lesser extent. Hormone changes appeared on the second day of drug administration and lasted up to 3-4 days after the drug was discontinued. In two patients with nonpituitary-dependent Cushing's syndrome, RU 486 induced no significant change in steroid secretion. We conclude that RU 486 induced a delayed and prolonged pituitary-adrenal response in Cushing's disease; whether the resulting cortisol overproduction will overcome the peripheral effect of RU 486 remains to be determined.
X Bertagna, and
C Bertagna, and
M H Laudat, and
J M Husson, and
F Girard, and
J P Luton
March 1988,
The Journal of clinical endocrinology and metabolism,
X Bertagna, and
C Bertagna, and
M H Laudat, and
J M Husson, and
F Girard, and
J P Luton
November 2007,
European journal of endocrinology,
X Bertagna, and
C Bertagna, and
M H Laudat, and
J M Husson, and
F Girard, and
J P Luton
January 1987,
European journal of clinical pharmacology,
X Bertagna, and
C Bertagna, and
M H Laudat, and
J M Husson, and
F Girard, and
J P Luton
July 1987,
Lancet (London, England),
X Bertagna, and
C Bertagna, and
M H Laudat, and
J M Husson, and
F Girard, and
J P Luton
November 1993,
Contraception,
X Bertagna, and
C Bertagna, and
M H Laudat, and
J M Husson, and
F Girard, and
J P Luton
September 1985,
The Journal of clinical endocrinology and metabolism,
X Bertagna, and
C Bertagna, and
M H Laudat, and
J M Husson, and
F Girard, and
J P Luton
May 1988,
Biochemical and biophysical research communications,
X Bertagna, and
C Bertagna, and
M H Laudat, and
J M Husson, and
F Girard, and
J P Luton
September 1988,
The Journal of clinical endocrinology and metabolism,
X Bertagna, and
C Bertagna, and
M H Laudat, and
J M Husson, and
F Girard, and
J P Luton
May 1989,
The American journal of physiology,
X Bertagna, and
C Bertagna, and
M H Laudat, and
J M Husson, and
F Girard, and
J P Luton
January 1997,
Experimental nephrology,
